Epstein Secrets

d that it was wrong and that it was stolen from him, but that he would acknowledge that Biden won and of course, leave the White House in January." Michael Shear of the New York Times said on CNN's Inside PoliticsVi (11/15, 766K), "It's the closest that we've seen to a kind of non-concession concession. I've

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

d that it was wrong and that it was stolen from him, but that he would acknowledge that Biden won and of course, leave the White House in January." Michael Shear of the New York Times said on CNN's Inside PoliticsVi (11/15, 766K), "It's the closest that we've seen to a kind of non-concession concession. I've

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

d that it was wrong and that it was stolen from him, but that he would acknowledge that Biden won and of course, leave the White House in January." Michael Shear of the New York Times said on CNN's Inside PoliticsVi (11/15, 766K), "It's the closest that we've seen to a kind of non-concession concession. I've

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying